BioXcel Therapeutics, Inc. Public Float
BioXcel Therapeutics, Inc. (BTAI) had Public Float of $11.02 million as of 2025-06-30, per its 10-K filed 2026-03-27.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-27
- 2025-06-30: Entity Public Float $11.02M.
- 2024-06-30: Entity Public Float $41.28M.
- 2023-06-30: Entity Public Float $134.94M.
- 2022-06-30: Entity Public Float $250.89M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $11.02M 10-K · filed 2026-03-27 |
| 2024-06-30 | $41.28M 10-K · filed 2025-03-28 |
| 2023-06-30 | $134.94M 10-K · filed 2024-03-22 |
| 2022-06-30 | $250.89M 10-K/A · filed 2023-05-01 |
| 2021-06-30 | $550.90M 10-K · filed 2022-03-11 |
| 2020-06-30 | $564.82M 10-K · filed 2021-03-12 |
| 2019-06-28 | $63.47M 10-K · filed 2020-03-09 |
| 2018-06-30 | $55.00M 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |